These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 34080686)

  • 41. Lower relapse rate of botulinum toxin A therapy for axillary hyperhidrosis by dose increase.
    Karamfilov T; Konrad H; Karte K; Wollina U
    Arch Dermatol; 2000 Apr; 136(4):487-90. PubMed ID: 10768647
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Botulinum toxin in focal hyperhidrosis. An update].
    Hosp C; Naumann MK; Hamm H
    Hautarzt; 2012 Jun; 63(6):469-76. PubMed ID: 22638981
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Botulinum toxin A for axillary hyperhidrosis (excessive sweating).
    Heckmann M; Ceballos-Baumann AO; Plewig G;
    N Engl J Med; 2001 Feb; 344(7):488-93. PubMed ID: 11172190
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Efficacy, side effects and patient satisfaction with wrist conduction block anaesthesia prior to the treatment of palmar hyperhidrosis with botulinum toxin type A].
    Siebert T; Sinkgraven R; Fuchslocher M; Rzany B
    J Dtsch Dermatol Ges; 2003 Nov; 1(11):876-83. PubMed ID: 16281578
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A randomized, double-blind, placebo-controlled trial of botulinum A toxin for severe axillary hyperhidrosis.
    Schnider P; Binder M; Kittler H; Birner P; Starkel D; Wolff K; Auff E
    Br J Dermatol; 1999 Apr; 140(4):677-80. PubMed ID: 10233320
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Botulinum toxin B in the treatment of craniofacial hyperhidrosis.
    Karlqvist M; Rosell K; Rystedt A; Hymnelius K; Swartling C
    J Eur Acad Dermatol Venereol; 2014 Oct; 28(10):1313-7. PubMed ID: 24118460
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Safety and prolonged efficacy of Botulin Toxin A in primary hyperhidrosis.
    D'Epiro S; Macaluso L; Salvi M; Luci C; Mattozzi C; Marzocca F; Salvo V; Scarnò M; Calvieri S; Richetta AG
    Clin Ter; 2014; 165(6):e395-400. PubMed ID: 25524193
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Update on pediatric hyperhidrosis.
    Gordon JR; Hill SE
    Dermatol Ther; 2013; 26(6):452-61. PubMed ID: 24552408
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Quality of life and social isolation in Greek adolescents with primary focal hyperhidrosis treated with botulinum toxin type A: a case series.
    Kouris A; Armyra K; Stefanaki C; Christodoulou C; Karimali P; Kontochristopoulos G
    Pediatr Dermatol; 2015; 32(2):226-30. PubMed ID: 25557249
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment of Hyperhidrosis: An Update.
    Henning MAS; Bouazzi D; Jemec GBE
    Am J Clin Dermatol; 2022 Sep; 23(5):635-646. PubMed ID: 35773437
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Muscle weakness in treatment of palmar hyperhidrosis with botulinum toxin type a: can it be prevented?
    Kouris A; Vavouli C; Markantoni V; Kontochristopoulos G
    J Drugs Dermatol; 2014 Nov; 13(11):1315-6. PubMed ID: 25607695
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treatment of focal hyperhidrosis.
    Murray CA; Cohen JL; Solish N
    J Cutan Med Surg; 2007; 11(2):67-77. PubMed ID: 17374317
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pilot study of the safety and efficacy of Myobloc (botulinum toxin type B) for treatment of axillary hyperhidrosis.
    Baumann L; Slezinger A; Halem M; Vujevich J; Martin LK; Black L; Bryde J
    Int J Dermatol; 2005 May; 44(5):418-24. PubMed ID: 15869543
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Topical botulinum toxin to treat hyperhidrosis? No sweat!
    Lim EC; Seet RC; Chow A; Oh VM; Ong BK; Wilder-Smith EP
    Med Hypotheses; 2006; 67(1):27-32. PubMed ID: 16524669
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Botulinum toxin type a is a safe and effective treatment for axillary hyperhidrosis over 16 months: a prospective study.
    Naumann M; Lowe NJ; Kumar CR; Hamm H;
    Arch Dermatol; 2003 Jun; 139(6):731-6. PubMed ID: 12810503
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dilution of botulinum toxin A in lidocaine vs. in normal saline for the treatment of primary axillary hyperhidrosis: a double-blind, randomized, comparative preliminary study.
    Güleç AT
    J Eur Acad Dermatol Venereol; 2012 Mar; 26(3):314-8. PubMed ID: 21492253
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Botulinum toxin for hyperhidrosis: a review.
    Grunfeld A; Murray CA; Solish N
    Am J Clin Dermatol; 2009; 10(2):87-102. PubMed ID: 19222249
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Onabotulinumtoxin type A (Botox(®)) versus Incobotulinumtoxin type A (Xeomin(®)) in the treatment of focal idiopathic palmar hyperhidrosis: results of a comparative double-blind clinical trial.
    Campanati A; Giuliodori K; Martina E; Giuliano A; Ganzetti G; Offidani A
    J Neural Transm (Vienna); 2014 Jan; 121(1):21-6. PubMed ID: 24052109
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hyperhidrosis: Management Options.
    McConaghy JR; Fosselman D
    Am Fam Physician; 2018 Jun; 97(11):729-734. PubMed ID: 30215934
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Botulinum toxin type A in the treatment of bilateral primary axillary hyperhidrosis: efficacy and duration with repeated treatments.
    Lowe PL; Cerdan-Sanz S; Lowe NJ
    Dermatol Surg; 2003 May; 29(5):545-8. PubMed ID: 12752526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.